Match!
Zoltán Kaló
Semmelweis University
Health careIntensive care medicinePhysical therapyHealth technologyMedicine
198Publications
20H-index
1,688Citations
What is this?
Publications 187
Newest
#1András Inotai (Semmelweis University)H-Index: 10
#2D Tomek (Slovak Medical University)H-Index: 6
Last. Zoltán Kaló (Semmelweis University)H-Index: 20
view all 9 authors...
Introduction: Although there is a significant utilization gap of biologic medicines in the EU, many studies estimate equity in patient access to biopharmaceuticals only based on their availability on the national list of reimbursed medicines. Hidden access barriers may facilitate financial sustainability of pharmaceuticals in less affluent EU countries; however, they have rarely been documented in scientific publications. Our objective was to explore these access barriers for tumor necrosis fact...
Source
Source
#1Bertalan NémethH-Index: 6
#2Wim Goettsch (UU: Utrecht University)H-Index: 27
Last. Zoltán Kaló (Semmelweis University)H-Index: 20
view all 9 authors...
Introduction: Lower income European countries have a worse health status and less funds for health care compared to Western Europe. Despite their limited human and financial capacities for conducti...
Source
#1Zsuzsanna Ida Petykó (Semmelweis University)
#2András Inotai (Semmelweis University)H-Index: 10
Last. Zoltán Kaló (Semmelweis University)H-Index: 20
view all 5 authors...
Introduction: Pharmaceutical research and development (R&D) is costly and only a minority of patients can access innovative medicines due to affordability constraints. Value added medicines (VAMs) can offer potential benefits at significantly lower R&D costs.Areas covered: VAMs may address different health care needs and problems, including off-label use of medicines, poor patient adherence, problems related to polypharmacy, need for home and/or personalized health care services. However, severa...
Source
#1A. Zemplényi (PTE: University of Pécs)H-Index: 3
#2Agnes Csikos (PTE: University of Pécs)H-Index: 12
Last. Zoltan Kalo (Semmelweis University)
view all 9 authors...
BACKGROUND: The Palliative Care Consult Service (PCCS) programme was among the first initiations in Hungary to provide palliative care for patients admitted to hospital. The PCCS team provides palliative care for mainly cancer patients and their family members and manages the patient pathway after being discharged from the hospital. The service started in 2014 with 300-400 patient visits per year. The aim of this study is to give a comprehensive overview of the PCCS programme guided by a concept...
Source
#1Cristina Rais (UMFCD: Carol Davila University of Medicine and Pharmacy)H-Index: 1
#2Zoltán Kaló (Semmelweis University)H-Index: 20
Last. Vlad Negulescu (UMFCD: Carol Davila University of Medicine and Pharmacy)
view all 4 authors...
Abstract Health Technology Assessment (HTA) is a complex methodology increasingly used worldwide to make transparent and evidence-based reimbursement decisions for health technologies. This study aims to describe the present environment and future prospects of HTA implementation in Romania based on the opinion of a wide range of national stakeholders. A survey was conducted using a questionnaire already applied previously to design HTA roadmaps for middle-income countries. Survey responses were ...
1 CitationsSource
#1Ahmad Fasseeh (ELTE: Eötvös Loránd University)H-Index: 1
#2Rita Karam (Lebanese University)H-Index: 3
Last. Julia ChamovaH-Index: 2
view all 13 authors...
Introduction: Implementation of health technology assessment (HTA) is still in an early stage with some heterogeneity in the Middle East and North Africa (MENA). Our objective was to assess the current and future status of HTA implementation in the MENA region by focusing on regional commonalities. Methods: Preparatory discussions for the first ISPOR conference in the MENA region indicated some potentially generalizable trends of HTA roadmaps. To widen the perspective, a policy survey was conduc...
2 CitationsSource
#1A. Inotai (Semmelweis University)H-Index: 4
#1András Inotai (Semmelweis University)H-Index: 10
Last. Zoltán Kaló (Semmelweis University)H-Index: 20
view all 2 authors...
Introduction: There is significant difference in utilisation of patented medicines in the EU, as pharmaceuticals at Western European price levels are usually not cost-effective in Central Eastern E...
Source
: The evidence base of policies that improve the timeliness of cancer care is under ongoing debate. Pancreatic cancer is frequently diagnosed in a stage when curative therapy is not feasible; hence, it is an important target for timelier healthcare interventions. The objectives of our research were to identify all clinical studies on pancreatic cancer care delays via a systematic literature review, to assess the study methodologies for possible biases, to conclude on the available evidence, and ...
Source
#1András Harsányi (ELTE: Eötvös Loránd University)H-Index: 7
#2Marcell Csanádi (PTE: University of Pécs)H-Index: 7
Last. András Inotai (ELTE: Eötvös Loránd University)H-Index: 10
view all 6 authors...
ABSTRACTObjectives: Utilization of multisource biological (off-patent originator and its biosimilar) medicines can improve the efficiency of resource allocation by 1) generating savings while maint...
1 CitationsSource
12345678910